Approval · Notice of Compliance 28682 · 2022
ENTROPHEN CHEWABLE: Notice of Compliance 28682
Issued August 2, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28682
- Date
- August 2, 2022
- Company
- Pendopharm Division Of Pharmascience IncMontreal, Quebec, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the Canadian Drug Facts Table (CDFT)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ENTROPHEN CHEWABLE | 02243974 | Marketed |
Medicinal ingredients
- ACETYLSALICYLIC ACID 81 MG per TAB